Green Cross Health (NZSE:GXH) ROCE %: 15.86% (As of Mar. 2026)


NZSE:GXH Green Cross Health Ltd NZSE:GXH
63 GF Score
Price NZ$2.00
GF Value NZ$1.08
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Green Cross Health ROCE %?

Green Cross Health NZSE:GXH +1.01% 63 ROCE % is 15.86% as of Mar. 2026. GuruFocus rates NZSE:GXH with a GF Score™ of 63/100 and a GF Value™ of NZ$1.08 (Significantly Overvalued). The stock has 7 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Green Cross Health's annualized ROCE % for the quarter that ended in Mar. 2026 was 15.86%.

Green Cross Health  (NZSE:GXH) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Green Cross Health ROCE % Related Terms

Green Cross Health ROCE % Historical Data

* Premium members only.

The historical data trend for Green Cross Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Green Cross Health ROCE % Chart

Green Cross Health Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.81 9.76 8.25 10.36 12.44

Green Cross Health Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.20 8.28 12.45 8.95 15.86
NZSE:GXH
63GF Score
Green Cross Health Ltd NZSE:GXH
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Green Cross Health ROCE % Calculation

Green Cross Health's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=37.408/( ( (386.237 - 84.669) + (392.027 - 92.085) )/ 2 )
=37.408/( (301.568+299.942)/ 2 )
=37.408/300.755
=12.44 %

Green Cross Health's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=47.784/( ( (392.931 - 90.323) + (392.027 - 92.085) )/ 2 )
=47.784/( ( 302.608 + 299.942 )/ 2 )
=47.784/301.275
=15.86 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.86% mean?
Green Cross Health (NZSE:GXH) has a ROCE % of 15.86% as of Mar. 2026.
Is Green Cross Health's ROCE % too high?
Green Cross Health's current ROCE % is 15.86%. The Healthcare Providers & Services industry median ROCE % is 6.41. Green Cross Health's value of 15.86% is 147.4% above this industry median. Overall, Green Cross Health has a GF Score™ of 63/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Green Cross Health's ROCE % compare to competitors?
Green Cross Health's ROCE % of 15.86% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Green Cross Health's value of 15.86% is 147.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 644 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Cross Health's current ROCE % of 15.86% is 147.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Cross Health's current ROCE % is 15.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Cross Health stock overvalued right now?
Based on GuruFocus' analysis, Green Cross Health (NZSE:GXH) is currently considered Significantly Overvalued. The stock's GF Value™ is NZ$1.08, compared to a current price of NZ$2.00 — trading 85.2% above its estimated fair value. The current ROCE % is 15.86% and 147.4% above the Healthcare Providers & Services industry median of 6.41. Green Cross Health's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Green Cross Health (NZSE:GXH), the current ROCE % is 15.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Green Cross Health (NZSE:GXH) Overvalued in 2026?

Based on GuruFocus' analysis, Green Cross Health stock appears to be overvalued. The current stock price of NZ$2.00 is trading 85.2% above its estimated GF Value™ of NZ$1.08. GuruFocus considers Green Cross Health to be Significantly Overvalued.

Key valuation signals for NZSE:GXH:

  • ROCE %: 15.86%
  • GF Value™: NZ$1.08 vs. price of NZ$2.00 (85.2% above fair value)
  • GF Score™: 63/100 with 7 warning signs
  • Industry Position: 147.4% above the Healthcare Providers & Services median

No single metric tells the full story. See the NZSE:GXH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Green Cross Health Business Description

Address 602 Great South Road, Ellerslie, Ground Floor, Building B, Millennium Centre, Auckland, NTL, NZL, 1051
Green Cross Health Ltd is engaged in providing healthcare services in New Zealand. The reportable segments of the group are Pharmacy services and medical services. The majority of the revenue is generated from the Pharmacy services segment. The pharmacy services segment provides retail and dispensary services, and the medical services segment provides GP, nursing, and urgent care services. The majority of its revenue is generated from the pharmacy segment.
63GF Score

Get the complete analysis for NZSE:GXH

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NZ$2.00
Price
NZ$1.08
GF Value